"35,000 annual deaths in Europe due to superbugs, says EU agency
As deaths due to antimicrobial resistance (AMR) rise, public health actions aimed at tackling AMR are insufficient, according to a report by the European Centre for Disease Prevention and Control (ECDC) published Thursday (17 November)"
"--START AD- #TheMummichogblogOfMalta Amazon Top and Flash Deals(Affiliate Link - You will support our translations if you purchase through the following link) - https://amzn.to/3CqsdJH
Compare all the top travel sites in just one search to find the best hotel deals at HotelsCombined - awarded world's best hotel price comparison site.
(Affiliate Link - You will support our translations if you purchase through the following link) - https://www.hotelscombined.com/?a_aid=20558
“So whatever you wish that others would do to you, do also to them, for this is the Law and the Prophets."""" #Jesus #Catholic.
Smooth Radio Malta is Malta’s number one digital radio station, playing Your Relaxing Favourites - Smooth provides a ‘clutter free’ mix, appealing to a core 35-59 audience offering soft adult contemporary classics. We operate a playlist of popular tracks which is updated on a regular basis. https://smooth.com.mt/listen/
Follow on Telegram: https://t.me/themummichogblogdotcom
END AD---"
".
The report also states that “AMR will be an increasing concern unless governments respond more robustly to the threat.”
In 2020, more than 800,000 infections due to resistant bacteria occurred in the EU/EEA, which directly resulted in the deaths of 35,000 people.
“This means that every day nearly 100 people die in the EU, Norway, and Iceland,” ECDC director Andrea Ammon said at a press briefing presenting the report.
“The burden of AMR in the EU remains similar to the burden of influenza, tuberculosis and HIV/AIDS combined,” Ammon added.
Antimicrobials include the subcategories antibiotics, antivirals, antifungals and antiparasitics, and are used to prevent and treat infections in humans, animals and plants.
According to the World Health Organisation (WHO), AMR occurs when bacteria, viruses, fungi and parasites change over time and stop responding to medicines. This complicates the treatment of infections.
AMR is driven by many factors, including widespread mis- and overuse of antibiotics in humans and animals worldwide.
AMR is a slow, silent pandemic, according to Ammon, who warned that we continue to see “high levels of AMR for several very important bacterial species” and that “new ones continue to emerge”.
In July, the Commission’s Health Emergency Preparedness and Response Authority (HERA) identified AMR as one of the top three health threats requiring coordinated EU action.
In 2019, it was estimated that AMR cost the healthcare systems of EU/EEA countries approximately €1.1 billion every year. This cost is bound to increase as AMR is on the rise and the development of new antimicrobials is slow.
Antibiotics
List of antimicrobials still disputed despite endorsement by member states
The EU member states have now formally given their support to the list of antimicrobials reserved for human use proposed by the Commission. Despite this, the criticism has not died down.
Burden in healthcare settings
According to Ammon, around 70% of the AMR burden is linked “with healthcare-associated infections”.
“[This] could be easily minimised through adequate infection prevention and control measures, as well as antibiotic stewardship in healthcare settings,” she said.
One positive development shown by the report is that the last 10 years have shown a decrease of 23% of the total antimicrobial consumption in humans in primary care and hospital sectors.
While this could show that we are moving in the right direction, Ammon advised keeping in mind that there could be missed factors lost in the disruption of the COVID-19 pandemic. This included considering how pandemic measures have affected healthcare-seeking behaviour and prescription beh